myeloproliferative
骨髓及外骨髓增殖的
常用释义
英音[ ˌmaɪələʊprəˈlɪfəreɪtɪv ]
美音[ ˈmaɪəloʊprəˈlɪfərətɪv ]
基本释义
- adj. 骨髓及外骨髓增殖的
例句
-
1·Objective to discuss the diagnosis and treatment of portal hypertension secondary to myeloproliferative diseases.目的探讨骨髓增生性疾病致门静脉高压症的诊断及治疗。
-
2·Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
-
3·Conditions included myelodysplastic syndrome, myeloproliferative disorders, acute myeloid leukemia, and bronchial carcinoma.疾病可引发脊髓发育不良、脊髓增殖失调，急性髓性白血病和支气管瘤。
-
4·In BCR-ABL fusion gene negative myeloproliferative diseases, the discovery of JAK2V617F point mutation is an important landmark.在BCR - ABL阴性的骨髓增殖性疾病的发病机制中，JAK2V 617 F点突变的发现是一个重大的突破。
-
5·Conclusions Myeloid sarcoma may precede, develop in a background of myeloproliferative disorder or even after remission of the disease.结论髓系肉瘤可孤立出现或发生于各种骨髓增生性疾病的病程中或经治疗缓解后。
-
6·Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis.这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。
-
7·There is high frequency of JAK2 V617F mutation in myeloproliferative disorders and it could be used as the diagnostic marker for myeloproliferative disorders.JAK2基因V617F突变在骨髓增殖性疾病中有较高的检出率，可作为骨髓增殖性疾病特异性诊断指标。
-
8·So SHP-2 could be the key element of the high value-added signal-regulated in myeloid cells and a important regulatory in the pathogenesis of myeloproliferative disorders.因此，SHP-2可能是髓系细胞高增殖性信号调控的关键分子，及髓系增殖性疾病的发病机制中重要的调控分子之一。
-
9·The experiment shows that the T-2 toxin is capable of inhibiting the growth of tumor cells and has good killing effect on the bone cancers and myeloproliferative disorder.实验证明：T - 2毒素可抑制肿瘤细胞生长，对骨癌及骨髓增生异常有良好的杀伤。
-
10·The results show that the examined patients are infected by HHV 6, which has a good relationship with leukemia, lymphoma, myeloproliferative disorder syndrome, and multiple myeloma.提示在所检病例中存在HHV?6感染，其中与急性白血病、淋巴瘤及骨髓增生异常综合症关系尤为密切。